You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

IOPAMIDOL-300 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Iopamidol-300, and when can generic versions of Iopamidol-300 launch?

Iopamidol-300 is a drug marketed by Abbvie, Cook Imaging, Fresenius Kabi Usa, and Hospira. and is included in seven NDAs.

The generic ingredient in IOPAMIDOL-300 is iopamidol. There are eleven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the iopamidol profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Iopamidol-300

A generic version of IOPAMIDOL-300 was approved as iopamidol by HAINAN POLY on February 27th, 2023.

  Try a Trial

Drug patent expirations by year for IOPAMIDOL-300
Recent Clinical Trials for IOPAMIDOL-300

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Army Medical Center of PLAN/A
Chongqing Emergency Medical CenterN/A
M.D. Anderson Cancer CenterN/A

See all IOPAMIDOL-300 clinical trials

US Patents and Regulatory Information for IOPAMIDOL-300

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie IOPAMIDOL-300 iopamidol INJECTABLE;INJECTION 074638-001 Apr 30, 1997 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hospira IOPAMIDOL-300 IN PLASTIC CONTAINER iopamidol INJECTABLE;INJECTION 074637-001 Apr 3, 1997 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hospira IOPAMIDOL-300 iopamidol INJECTABLE;INJECTION 074898-003 Dec 30, 1997 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.